Clinical Trial Update: An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects [Phase 2]

View source ↗

Summary

Open-label Phase 2 pediatric study evaluating emtricitabine in combination with other antiretrovirals for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 2 | Status: COMPLETED